Sangamo Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on Sangamo Therapeutics Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Sangamo Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Sangamo Therapeutics Inc.

Back to companies

Sangamo Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Sangamo Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sangamo Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Sandy Macrae

Chief Executive Officer; Director Executive Board

Mr Sandy Macrae serves as the Chief Executive Officer and Director of the company. Prior to this, he served as the Global Medical Officer at Takeda Pharmaceuticals. Previously, he served as the Senior Vice President at GlaxoSmithKline.

Read Hide full bio of Sandy Macrae

Alexander D. Macrae, PhD

President; Chief Executive Officer; Director Executive Board Since: 2016 Age: 62

Mr Alexander D. Macrae has been the President, Chief Executive Officer, and Director of the company since 2016. Prior to this, he served as the director at 4D Pharma plc. Previously, he served as the Global Medical Officer at Takeda Pharmaceuticals.

Read Hide full bio of Alexander D. Macrae, PhD

Scott B. Willoughby

Secretary; Chief Legal Officer Senior Management Since: 2021 Age: 50

Mr Scott B. Willoughby has been the Chief Legal Officer and Corporate Secretary of the company since 2021. Prior to this, he served as General Counsel, Corporate Secretary, and Head of Corporate Law of the company. Previously, he served as the Deputy General Counsel at Achaogen Inc.

Read Hide full bio of Scott B. Willoughby

Nathalie Dubois Stringfellow, PhD

Chief Development Officer Senior Management Since: 2022 Age: 63

Ms Nathalie Dubois Stringfellow has been the Chief Development Officer of the company since 2022. Prior to this, she served as the Senior Vice President of the company. Previously, he served in various positions at Chiron Corp, Bayer Corp, and Signature Biosciences Inc.

Read Hide full bio of Nathalie Dubois Stringfellow, PhD

Phillip Ramsey

Chief Technical Officer Senior Management

Mr Phillip Ramsey is the Chief Technical Officer of the company. Prior to this, he served as Senior Director at Emergent BioSolutions. Previously, he has over 35 years of experience in biotech and pharmaceutical operations, development, and quality.

Read Hide full bio of Phillip Ramsey
Gain a 360-degree view of Sangamo Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Sangamo Therapeutics Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer